iBio Inc.

iBio Technology

iBio Technology is a Transformative Patented Technology for Biotherapeutics and Vaccines

View iBio Technology

Product Pipeline

IBIO-CFB03

iBio is developing a proprietary therapeutic product for the treatment of idiopathic pulmonary fibrosis (IPF), systemic scleroderma and other fibrotic diseases

View IBIO-CFB03
Phase completed
not started
not started
not started
not started
not started
Preclinical Phase 1 Phase 2a Phase 2b Phase 3 Market

Partners

Biotechnology and pharmaceutical companies are currently out-licensing the iBio Technology platform, among other collaborative efforts.

View Partners

About iBio

iBio, Inc., a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.

More About iBio

Investor Relations

iBio Inc. NYSE MKT: IBIO Loading...
Volume Loading...
Day Low/High Loading...
52 Wk Range Loading...